SAM
IART icon

Smartleaf Asset Management’s Integra LifeSciences IART Stock Holding History

Smartleaf Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14
Closed -$178 – 3589
2025
Q4 		$178 Buy
+14
New +$186 ﹤0.01% 3373
2025
Q2 		– Sell
-11
Closed -$238 – 2839
2025
Q1 		$238 Sell
11
-6
-35% -$141 ﹤0.01% 2775
2024
Q4 		$381 Sell
17
-69
-80% -$1.51K ﹤0.01% 2815
2024
Q3 		$1.54K Sell
86
-2,802
-97% -$64.9K ﹤0.01% 2560
2024
Q2 		$83K Sell
2,888
-88
-3% -$2.61K 0.01% 628
2024
Q1 		$104K Buy
2,976
+87
+3% +$3.48K 0.02% 507
2023
Q4 		$127K Buy
+2,889
New +$114K 0.03% 388

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Smartleaf Asset Management's IART Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 14 shares — an estimated $178 sold.

Smartleaf Asset Management first reported a position in IART in Q4 2023 and held it in 7 quarters. The position peaked at $127K in Q4 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Smartleaf Asset Management reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 14 Integra LifeSciences shares in Q1 2026, an estimated $178.
  • Smartleaf Asset Management first reported a position in Integra LifeSciences in Q4 2023 and held it in 7 quarters.
  • Smartleaf Asset Management's Integra LifeSciences position peaked at $127K in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.